MTRN.NYSEMaterion CORP

Form 4: Materion CFO's Equity Transactions Detailed

Sentiment:

Insider Transaction Report


Materion's VP of Finance and CFO, Shelly Marie Chadwick, reported a series of equity transactions including RSU vesting, tax-related disposals, and sales under a 10b5-1 plan, alongside new RSU and SAR grants.

Summary

  • Shelly Marie Chadwick, Vice President, Finance & CFO of Materion Corp. (MTRN), reported multiple equity transactions.
  • On March 1, 2026, 5,552 Restricted Stock Units (RSUs) vested and converted into common stock.
  • On March 2, 2026, 3,909 shares of common stock were disposed of at $166.59 per share to cover tax liabilities related to the RSU vesting.
  • On March 3, 2026, 1,039 shares were sold at $157.26 per share, executed under a Rule 10b5-1 trading plan adopted on December 1, 2025.
  • An additional 1,500 shares were sold on March 3, 2026, at $162 per share.
  • Following these transactions, the reporting person beneficially owns 15,243 shares of common stock.
  • On March 1, 2026, Ms. Chadwick was granted 3,590 new Restricted Stock Units (RSUs) and 5,498 Stock Appreciation Rights (SARs).
  • The newly granted RSUs and SARs will vest in three equal annual installments beginning March 1, 2027.
  • The SARs have an exercise price of $166.59 and an expiration date of March 1, 2033.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. While there are sales, they are largely offset by RSU vesting and new equity grants, and one sale was pre-planned, indicating routine compensation management rather than a negative signal.

Positives

  • Grant of 3,590 new Restricted Stock Units (RSUs) to the CFO.
  • Grant of 5,498 new Stock Appreciation Rights (SARs) to the CFO, aligning her interests with long-term shareholder value.
  • Vesting of 5,552 previously granted Restricted Stock Units, indicating successful achievement of prior compensation milestones.

Negatives

  • Disposal of 3,909 shares of common stock to cover tax liabilities.
  • Sale of 1,039 shares of common stock under a pre-arranged 10b5-1 trading plan.
  • Sale of an additional 1,500 shares of common stock.

Future Outlook

The newly granted Restricted Stock Units and Stock Appreciation Rights are scheduled to vest in three equal annual installments beginning March 1, 2027, indicating a long-term incentive structure for the CFO.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving equity compensation and pre-planned sales (10b5-1 plans), are common across industries. The grant of new equity awards aligns the CFO's incentives with long-term company performance, a standard practice in executive compensation.

Stakeholder Impact

  • Shareholders: The CFO's continued equity ownership and new grants align her interests with shareholder value creation, though sales reduce her direct holdings.
  • Employees: Standard executive compensation practices are demonstrated, which can influence overall compensation philosophy.

Next Steps

  • Future vesting of newly granted Restricted Stock Units in three equal annual installments beginning March 1, 2027.
  • Future vesting of newly granted Stock Appreciation Rights in three equal annual installments beginning March 1, 2027.

Key Dates

DateDescription
12/01/2025Date Rule 10b5-1 trading plan was adopted by the Reporting Person.
03/01/2026Date of RSU vesting and conversion to common stock, and grant of new RSUs and SARs.
03/02/2026Date of disposal of common stock for tax liability.
03/03/2026Date of common stock sales, including one under a 10b5-1 plan.
03/01/2027Beginning of vesting for newly granted Restricted Stock Units and Stock Appreciation Rights.
03/01/2033Expiration date for newly granted Stock Appreciation Rights.

Recommendation

hold

The filing details routine insider transactions for Materion's CFO, including RSU vesting, tax-related sales, and new equity grants. One significant sale was pre-planned under a 10b5-1 plan, which typically mitigates concerns about negative insider sentiment. The new grants of RSUs and SARs demonstrate continued alignment of management incentives with long-term company performance. These transactions do not provide new fundamental information about the company's operational or financial health to warrant a change in investment stance, thus a 'hold' recommendation is appropriate.

Keywords

Materion, MTRN, Insider Trading, Form 4, Shelly Marie Chadwick, CFO, Stock Sales, RSU Vesting, Stock Appreciation Rights, Equity Compensation, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.